|
Saturday, April 21, 2018 5:03 AM
|
Venöse Multiple Sklerose, CVI & SVI, CCSVI shared The Vascular Connection to Multiple Sclerosis's post.
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'  Cures are not good for business. Keeping people sick and scared makes more $. But we all know better, right? #MSHope #ItsNotAPill #LivingProof
|